Acquiring Company
Sun Pharmaceutical Industries
Acquired Company
Taro Pharmaceutical Industries
Mumbai
United StatesBiotechnologyHealth CarePharmaceuticalManufacturingBiotechnologyPharmaceuticalDescription
Sun Pharmaceutical Industries has announced the acquisition of Taro Pharmaceutical Industries, with a cash merger priced at USD 32.25 per share. The deal concludes Taro's independent listing and secures a cash payout for existing shareholders. This strategic move aligns with Sun Pharma's efforts to streamline its corporate structure and reduce complexity. The merger is set to finalize on September 17, 2026.
Quick answer
Sun Pharmaceutical Industries is acquiring Taro Pharmaceutical Industries, announced September 17, 2026. Sun Pharmaceutical Industries is based in Mumbai, Maharashtra, India.
- How much did Sun Pharmaceutical Industries pay for Taro Pharmaceutical Industries?
- The deal value was not disclosed.
- What does Sun Pharmaceutical Industries do?
- Sun Pharmaceutical Industries is a global pharmaceutical company based in India.
- Where are Sun Pharmaceutical Industries and Taro Pharmaceutical Industries based?
- Sun Pharmaceutical Industries is based in Mumbai, Maharashtra, India. Taro Pharmaceutical Industries is based in United States.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Zeria Pharmaceutical acquires Haupt Pharma Wulfling (October 25, 2026)
- Laprophan acquires Corporate Investment Holding (October 21, 2026)
- Senores Pharma acquires 75% stake in Apnar Pharma (August 30, 2026)
- Tarsus Pharmaceuticals to acquire Alkeus Pharmaceuticals (August 6, 2026)
- Western Microsurgical acquires Q Surgical and Proficient Surgical (October 27, 2026)
- Merck KGaA to acquire Silence Therapeutics for $1.3B, $1.3B (October 19, 2026)
Who to call at Sun Pharmaceutical Industries, and when
When Sun Pharmaceutical Industries changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Sun Pharmaceutical Industries raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Sun Pharmaceutical Industries, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Sun Pharmaceutical Industries. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Sun Pharmaceutical Industries makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries was acquired by Sun Pharmaceutical Industries, based in Mumbai. The deal was reported on September 17, 2026. Sun Pharmaceutical Industries is a global pharmaceutical company based in India. It specializes in providing high-quality medicines across various therapeutic areas, including oncology. Sun Pharmaceutical Industries is privately held and operates in Biotechnology.
When did Sun Pharmaceutical Industries acquire Taro Pharmaceutical Industries?
Sun Pharmaceutical Industries's acquisition of Taro Pharmaceutical Industries was reported on September 17, 2026. Sun Pharmaceutical Industries has announced the acquisition of Taro Pharmaceutical Industries, with a cash merger priced at USD 32.25 per share. The deal concludes Taro's independent listing and secures a cash payout for existing shareholders. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Taro Pharmaceutical Industries do?
Taro Pharmaceutical Industries is a specialty pharmaceutical company focused on dermatology and other therapeutic areas. It develops, manufactures, and markets pharmaceutical products for human use. It is privately held, operating in Manufacturing, and is based in United States.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.